CONCLUSIONS In patients with ULMCA disease and reduced LVEF, we found no significant difference in rates of the composite end point between patients receiving PCI and those undergoing CABG at 1 year follow-up.
CONCLUSIONS Robotic-assisted PCI had significantly lower incidence of LGM compared to standard manual PCI. These results suggest that R-PCI may reduce the incidence of LGM. Further studies are needed to confirm the results and elucidate their impact on outcomes. (Figure) . At 3 years of follow-up, patients treated with high-volume operators showed significantly lower rate of cardiac death (2.5% vs. 4.6%, p¼0.02), with no significant difference in rate of ischemia driven target vessel revascularization (6.8% vs. 5.1%. p¼0.20) when compared with the low-volume operators. After multivariate analysis, high-volume LM operator group was associated with freedom of 3-year cardiac death (adjusted HR 1.90 95% CI ¼ [1.10, 3.30] p ¼ 0.02).
CONCLUSIONS Despite treating more complex and higher-risk patients, high-volume operators had better short and long-term prognostic compared with low-volume operators when performing LM-PCI. These findings could be important when considering minimal operator's volume requirement for the treatment of this high-risk lesion subset. RESULTS Out of 15,988 patients included in the present analysis, 10,764 (67%) were males and 5224 (33%) were females. Of them, 1,198 (7%) and 672 (4%) presented with an MI in the male and female group, respectively. In both groups, women were older, more commonly affected by multiple comorbidities but had lower CAD complexity compared with men. A stepwise increase in the rates of mortality, MI and CVE was observed in the transition from male with no MI, to female with no MI, to male with MI to female with MI ( Figure 1) . Following multivariable adjustment for baseline confounders, women with MI had similar risk of all-cause mortality (HR: 1.02; 95% CI: 0.81 -1.28), MI (HR: 1.55; 95% CI: 0.93 -2.59) and CVE (HR: 2.44; 95% CI: 0.64 -9.36) to that of the male counterpart. The effect of gender across clinical presentation was uniform, without evidence for interaction for the investigated outcomes.
